$ALTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALLOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALLOS THERAPEUTICS INC. Get notifications about new insider transactions in ALLOS THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 04 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Nov 30 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 17,760 | |
Nov 30 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 6.72 | 1,500 | 10,080 | 31,920 | 33.4 K to 31.9 K (-4.49 %) |
Nov 30 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Nov 09 2007 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Principal Financial ... | Option Exercise | A | 4.78 | 20,000 | 95,600 | 20,000 | |
Nov 09 2007 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Principal Financial ... | Option Exercise | D | 4.50 | 20,000 | 90,000 | 0 | |
Nov 09 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 9.02 | 4,713 | 42,511 | 4,713 | |
Nov 09 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | D | 9.01 | 4,713 | 42,464 | 7,192 | |
Nov 02 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 19,260 | |
Nov 02 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 5.84 | 1,500 | 8,767 | 31,920 | 33.4 K to 31.9 K (-4.49 %) |
Nov 02 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Oct 17 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 20,760 | |
Oct 17 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 6.23 | 1,500 | 9,345 | 31,920 | 33.4 K to 31.9 K (-4.49 %) |
Oct 17 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Oct 09 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 22,260 | |
Oct 09 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 5.42 | 1,500 | 8,130 | 31,920 | 33.4 K to 31.9 K (-4.49 %) |
Oct 09 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Aug 14 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 23,760 | |
Aug 14 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 5.42 | 1,500 | 8,130 | 31,920 | 33.4 K to 31.9 K (-4.49 %) |
Aug 14 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,420 | 31.9 K to 33.4 K (+4.70 %) |
Jul 02 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.82 | 253 | 460 | 31,920 | 31.7 K to 31.9 K (+0.80 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.55 | 1,950 | 10,825 | 190,017 | 192 K to 190 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.85 | 3,880 | 22,688 | 191,967 | 195.8 K to 192 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.64 | 16,450 | 92,747 | 195,847 | 212.3 K to 195.8 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.76 | 3,545 | 20,406 | 212,297 | 215.8 K to 212.3 K (-1.64 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.55 | 2,063 | 11,452 | 201,087 | 203.2 K to 201.1 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.85 | 4,107 | 24,016 | 203,150 | 207.3 K to 203.2 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.64 | 17,408 | 98,148 | 207,257 | 224.7 K to 207.3 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.76 | 3,750 | 21,586 | 224,665 | 228.4 K to 224.7 K (-1.64 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 5.55 | 23,100 | 128,235 | 2,251,147 | 2.3 M to 2.3 M (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 5.85 | 45,968 | 268,798 | 2,274,247 | 2.3 M to 2.3 M (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 5.64 | 194,879 | 1,098,747 | 2,320,215 | 2.5 M to 2.3 M (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 5.76 | 41,996 | 241,742 | 2,515,094 | 2.6 M to 2.5 M (-1.64 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.55 | 897 | 4,980 | 87,374 | 88.3 K to 87.4 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.85 | 1,784 | 10,432 | 88,271 | 90.1 K to 88.3 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.64 | 7,564 | 42,647 | 90,055 | 97.6 K to 90.1 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 5.76 | 1,630 | 9,383 | 97,619 | 99.2 K to 97.6 K (-1.64 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 5.55 | 61,690 | 342,460 | 6,011,855 | 6.1 M to 6 M (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 5.85 | 122,761 | 717,845 | 6,073,545 | 6.2 M to 6.1 M (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 5.64 | 520,439 | 2,934,287 | 6,196,306 | 6.7 M to 6.2 M (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 5.76 | 112,152 | 645,581 | 6,716,745 | 6.8 M to 6.7 M (-1.64 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 25,260 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 6.63 | 1,500 | 9,945 | 31,667 | 33.2 K to 31.7 K (-4.52 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,167 | 31.7 K to 33.2 K (+4.74 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | RINGO WILLIAM R | Director | Option Exercise | A | 5.63 | 20,000 | 112,600 | 20,000 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | LYNCH TIMOTHY P | Director | Option Exercise | A | 5.63 | 20,000 | 112,600 | 20,000 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Director | Option Exercise | A | 5.63 | 50,000 | 281,500 | 50,000 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Option Exercise | A | 5.63 | 20,000 | 112,600 | 20,000 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Option Exercise | A | 5.63 | 20,000 | 112,600 | 20,000 | |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | CASEY MICHAEL D | Director | Option Exercise | A | 5.63 | 20,000 | 112,600 | 20,000 | |
Jun 08 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 5.63 | 1,100 | 6,193 | 102,500 | 103.6 K to 102.5 K (-1.06 %) |
Jun 08 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 5.62 | 1,000 | 5,620 | 103,600 | 104.6 K to 103.6 K (-0.96 %) |
Jun 08 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 5.61 | 3,100 | 17,391 | 104,600 | 107.7 K to 104.6 K (-2.88 %) |
Jun 08 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Sell | S | 5.60 | 4,800 | 26,880 | 107,700 | 112.5 K to 107.7 K (-4.27 %) |
Jun 04 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 26,760 | |
Jun 04 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 5.77 | 1,500 | 8,659 | 31,667 | 33.2 K to 31.7 K (-4.52 %) |
Jun 04 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,167 | 31.7 K to 33.2 K (+4.74 %) |
May 08 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 2.42 | 1,500 | 3,630 | 28,260 | |
May 08 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Sell | S | 6.09 | 1,500 | 9,134 | 31,667 | 33.2 K to 31.7 K (-4.52 %) |
May 08 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 2.42 | 1,500 | 3,630 | 33,167 | 31.7 K to 33.2 K (+4.74 %) |
Apr 26 2007 | ALTH | ALLOS THERAPEUTICS ... | LATTS JEFFREY | Director | Option Exercise | A | 6.47 | 25,000 | 161,750 | 25,000 | |
Mar 20 2007 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Option Exercise | A | 6.17 | 300,000 | 1,851,000 | 300,000 | |
Mar 20 2007 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sr. VP, Chief Medic ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Mar 14 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Sell | S | 6.45 | 23,625 | 152,466 | 283,875 | 307.5 K to 283.9 K (-7.68 %) |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Option Exercise | A | 7.47 | 60,000 | 448,200 | 60,000 | |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 7.47 | 43,750 | 326,813 | 43,750 | |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | A | 7.47 | 75,000 | 560,250 | 75,000 | |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 7.47 | 43,750 | 326,813 | 43,750 | |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | A | 7.47 | 150,000 | 1,120,500 | 150,000 | |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Option Exercise | A | 7.47 | 50,000 | 373,500 | 50,000 | |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 76,772 | 460,632 | 228,415 | 151.6 K to 228.4 K (+50.63 %) |
Feb 20 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Option Exercise | A | 7.47 | 275,000 | 2,054,250 | 275,000 | |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.00 | 2,340,978 | 14,045,868 | 6,828,897 | 4.5 M to 6.8 M (+52.16 %) |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 838,296 | 5,029,776 | 2,557,090 | 1.7 M to 2.6 M (+48.77 %) |
Jan 09 2007 | ALTH | ALLOS THERAPEUTICS ... | RINGO WILLIAM R | Director | Option Exercise | A | 6.00 | 25,000 | 150,000 | 25,000 | |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 43,954 | 263,724 | 99,249 | 55.3 K to 99.2 K (+79.49 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Buy | P | 1.82 | 2,500 | 4,548 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | Malek Eric | VP of Corporate Dev ... | Buy | P | 1.82 | 1,223 | 2,225 | 39,196 | 38 K to 39.2 K (+3.22 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.82 | 2,247 | 4,087 | 31,667 | 29.4 K to 31.7 K (+7.64 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.82 | 1,210 | 2,201 | 9,884 | 8.7 K to 9.9 K (+13.95 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | P | 1.82 | 2,500 | 4,548 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Buy | P | 3.05 | 2,500 | 7,629 | 112,500 | 110 K to 112.5 K (+2.27 %) |
Jan 03 2007 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | P | 3.05 | 2,500 | 7,629 | 307,500 | 305 K to 307.5 K (+0.82 %) |
Nov 30 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.50 | 77,313 | 425,222 | 1,718,794 | 1.6 M to 1.7 M (+4.71 %) |
Nov 30 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.50 | 215,309 | 1,184,200 | 4,487,919 | 4.3 M to 4.5 M (+5.04 %) |
Nov 30 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.50 | 7,378 | 40,579 | 151,643 | 144.3 K to 151.6 K (+5.11 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.75 | 30,175 | 173,392 | 1,641,481 | 1.6 M to 1.6 M (+1.87 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.80 | 40,671 | 236,010 | 1,611,306 | 1.6 M to 1.6 M (+2.59 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.66 | 120,702 | 682,811 | 1,570,635 | 1.4 M to 1.6 M (+8.32 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.75 | 82,023 | 471,321 | 4,272,610 | 4.2 M to 4.3 M (+1.96 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.80 | 110,553 | 641,528 | 4,190,587 | 4.1 M to 4.2 M (+2.71 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.66 | 328,092 | 1,856,016 | 4,080,034 | 3.8 M to 4.1 M (+8.74 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.75 | 2,802 | 16,101 | 144,265 | 141.5 K to 144.3 K (+1.98 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.80 | 3,776 | 21,912 | 141,463 | 137.7 K to 141.5 K (+2.74 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.66 | 11,206 | 63,392 | 137,687 | 126.5 K to 137.7 K (+8.86 %) |
Jul 05 2006 | ALTH | ALLOS THERAPEUTICS ... | Malek Eric | VP of Corporate Dev ... | Buy | P | 1.82 | 1,209 | 2,199 | 37,973 | 36.8 K to 38 K (+3.29 %) |
Jul 05 2006 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.82 | 195 | 355 | 29,420 | 29.2 K to 29.4 K (+0.67 %) |
Jul 05 2006 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.82 | 1,290 | 2,347 | 8,674 | 7.4 K to 8.7 K (+17.47 %) |
Jul 05 2006 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | P | 1.82 | 1,888 | 3,434 | 2,500 | 612 to 2.5 K (+308.50 %) |
Jun 06 2006 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Option Exercise | A | 3.13 | 350,000 | 1,095,500 | 350,000 | |
Jun 06 2006 | ALTH | ALLOS THERAPEUTICS ... | CARUSO JAMES V | Chief Commercial Of ... | Grant | A | 0.00 | 110,000 | 0 | 110,000 | 0 to 110 K |
May 30 2006 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Option Exercise | M | 0.56 | 50,000 | 28,225 | 190,250 | ||
May 30 2006 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Sell | S | 3.10 | 50,000 | 155,000 | 2,000 | 52 K to 2 K (-96.15 %) | |
May 30 2006 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Buy | M | 0.56 | 50,000 | 28,225 | 52,000 | 2 K to 52 K (+2,500.00 %) | |
May 16 2006 | ALTH | ALLOS THERAPEUTICS ... | JAFFE MARVIN | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | LYNCH TIMOTHY P | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | A | 2.94 | 50,000 | 147,000 | 50,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | EDWARDS MARK G | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 12 2006 | ALTH | ALLOS THERAPEUTICS ... | CASEY MICHAEL D | Director | Option Exercise | A | 2.94 | 20,000 | 58,800 | 20,000 | |
May 11 2006 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Option Exercise | A | 2.93 | 27,000 | 79,110 | 27,000 | |
Apr 17 2006 | ALTH | ALLOS THERAPEUTICS ... | BERNS PAUL L | Chief Executive Off ... | Buy | P | 2.94 | 5,000 | 14,700 | 305,000 | 300 K to 305 K (+1.67 %) |
Mar 07 2006 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 3.55 | 50,000 | 177,500 | 50,000 | |
Mar 02 2006 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | A | 3.42 | 5,000 | 17,100 | 5,000 | |
Feb 22 2006 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | A | 3.32 | 20,000 | 66,400 | 20,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | Malek Eric | VP of Corporate Dev ... | Option Exercise | A | 2.70 | 50,000 | 135,000 | 50,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 2.70 | 60,000 | 162,000 | 60,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Option Exercise | A | 2.70 | 40,000 | 108,000 | 40,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 2.70 | 90,000 | 243,000 | 90,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | DELONG DAVID A | Vice President, Sal ... | Option Exercise | A | 2.70 | 100,000 | 270,000 | 100,000 | |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | A | 2.70 | 100,000 | 270,000 | 100,000 | |
Jan 18 2006 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 2.29 | 250 | 573 | 250 | 0 to 250 |
Feb 14 2006 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Option Exercise | A | 2.70 | 100,000 | 270,000 | 100,000 | |
Jan 03 2006 | ALTH | ALLOS THERAPEUTICS ... | Malek Eric | VP of Corporate Dev ... | Buy | P | 1.82 | 904 | 1,644 | 36,764 | 35.9 K to 36.8 K (+2.52 %) |
Jan 03 2006 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Buy | P | 1.82 | 2,500 | 4,548 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Jan 03 2006 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.82 | 2,305 | 4,193 | 29,225 | 26.9 K to 29.2 K (+8.56 %) |
Jan 03 2006 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.82 | 1,363 | 2,479 | 7,384 | 6 K to 7.4 K (+22.64 %) |
Jan 03 2006 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Buy | P | 1.82 | 612 | 1,113 | 612 | 0 to 612 |
Oct 18 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 0.56 | 5,146 | 2,882 | 0 | |
Oct 18 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | M | 0.40 | 12,400 | 4,960 | 0 | |
Oct 18 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 0.56 | 5,146 | 2,882 | 26,920 | 21.8 K to 26.9 K (+23.63 %) |
Oct 18 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | M | 0.40 | 12,400 | 4,960 | 21,774 | 9.4 K to 21.8 K (+132.28 %) |
Jul 05 2005 | ALTH | ALLOS THERAPEUTICS ... | Malek Eric | VP of Corporate Dev ... | Buy | P | 1.85 | 286 | 530 | 35,860 | 35.6 K to 35.9 K (+0.80 %) |
Jul 05 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.85 | 335 | 621 | 9,374 | 9 K to 9.4 K (+3.71 %) |
Jul 05 2005 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Buy | P | 1.85 | 272 | 504 | 1,257 | 985 to 1.3 K (+27.61 %) |
Jul 05 2005 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.85 | 1,136 | 2,105 | 6,021 | 4.9 K to 6 K (+23.25 %) |
May 26 2005 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | M | 0.56 | 186,000 | 104,997 | 0 | |
May 26 2005 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | M | 0.40 | 62,000 | 24,998 | 0 | |
May 26 2005 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Buy | M | 0.56 | 186,000 | 104,997 | 474,870 | 288.9 K to 474.9 K (+64.39 %) |
May 26 2005 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Buy | M | 0.40 | 62,000 | 24,998 | 288,870 | 226.9 K to 288.9 K (+27.33 %) |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | A | 2.18 | 50,000 | 109,000 | 50,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | EDWARDS MARK G | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | JAFFE MARVIN | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | CASEY MICHAEL D | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | WARBURG PINCUS PRIVATE EQUITY ... | 10% Owner | Option Exercise | C | 0.00 | 2,262,443 | 0 | 0 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | WARBURG PINCUS PRIVATE EQUITY ... | 10% Owner | Buy | C | 0.00 | 22,624,430 | 0 | 22,624,430 | 0 to 22.6 M |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Option Exercise | A | 2.46 | 20,000 | 49,200 | 20,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Option Exercise | C | 0.00 | 2,262,443 | 0 | 0 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | HEN STEWART | Director | Buy | C | 0.00 | 22,624,430 | 0 | 22,624,430 | 0 to 22.6 M |